anmelden
SMI Expanded
1.848,96
PKT
+6,23
PKT
+0,34
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.02.19 | Zurich Insurance Neutral | UBS AG | |
| 08.02.19 | Zurich Insurance Outperform | Credit Suisse Group | |
| 08.02.19 | ams-OSRAM buy | Deutsche Bank AG | |
| 07.02.19 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 07.02.19 | ams-OSRAM overweight | Barclays Capital | |
| 07.02.19 | Givaudan Neutral | Credit Suisse Group | |
| 07.02.19 | Zurich Insurance Neutral | UBS AG | |
| 07.02.19 | Holcim Neutral | Goldman Sachs Group Inc. | |
| 07.02.19 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 07.02.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 06.02.19 | Holcim Sell | UBS AG | |
| 06.02.19 | ams-OSRAM buy | Kepler Cheuvreux | |
| 06.02.19 | ams-OSRAM verkaufen | Credit Suisse Group | |
| 06.02.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 06.02.19 | ams-OSRAM Hold | Hauck & Aufhäuser Privatbankiers KGaA | |
| 06.02.19 | Novartis Hold | HSBC | |
| 06.02.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 05.02.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 05.02.19 | ams-OSRAM buy | Kepler Cheuvreux | |
| 05.02.19 | ams-OSRAM overweight | Barclays Capital | |
| 05.02.19 | ams-OSRAM Neutral | UBS AG | |
| 05.02.19 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 05.02.19 | ams-OSRAM Underperform | Credit Suisse Group | |
| 04.02.19 | Zurich Insurance buy | Merrill Lynch & Co., Inc. | |
| 04.02.19 | Roche buy | Jefferies & Company Inc. | |
| 04.02.19 | UBS buy | UBS AG | |
| 04.02.19 | UBS buy | Deutsche Bank AG | |
| 04.02.19 | Roche Reduce | HSBC | |
| 04.02.19 | Holcim Hold | HSBC | |
| 04.02.19 | Novartis Hold | Deutsche Bank AG | |
| 01.02.19 | Roche Reduce | HSBC | |
| 01.02.19 | Zurich Insurance Neutral | UBS AG | |
| 01.02.19 | Swiss Re Sell | UBS AG | |
| 01.02.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 01.02.19 | Novartis Underweight | Barclays Capital | |
| 01.02.19 | ams-OSRAM overweight | Barclays Capital | |
| 01.02.19 | Roche Neutral | Credit Suisse Group | |
| 01.02.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.19 | Roche Neutral | UBS AG | |
| 31.01.19 | Roche Hold | Deutsche Bank AG |